Imaging

Oncology·MeSH: Colorectal Neoplasms

15 drugs in development·8 companies·2 clinical trials

Drug Pipeline by Phase

Approved(11)

Drug	Company
ammonia n 13	BRIGHT MINDS BIOSCIENCES INC. (DRUG)
CARDIOLITE	Lantheus Holdings, Inc. (LNTH)
cerianna	GE HealthCare Technologies Inc. (GEHC)
clariscan	GE HealthCare Technologies Inc. (GEHC)
fludeoxyglucose f18	BRIGHT MINDS BIOSCIENCES INC. (DRUG)
fludeoxyglucose f18	Cardinal Health Inc. (CAH)
lymphoseek kit	Cardinal Health Inc. (CAH)
PYLARIFY	Lantheus Holdings, Inc. (LNTH)
sincalide	MAIA Biotechnology, Inc. (MAIA)
sodium fluoride f-18	BRIGHT MINDS BIOSCIENCES INC. (DRUG)
technetium tc 99m sestamibi	Cardinal Health Inc. (CAH)

Phase 3(1)

Drug	Company
hrs-9231	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)

Phase 2(1)

Drug	Company
FG-3180	KYNTRA BIO INC. (KYNB)

Phase 1(1)

Drug	Company
lnth-2403	Radiopharm Theranostics Limited (RADX)

N/A(1)

Drug	Company
MK-6240	Lantheus Holdings, Inc. (LNTH)

BioSniper tracks 15 drugs in development for Imaging across 8 companies.

There are 2 clinical trials targeting Imaging tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.